Dr. Napoleon Puente Cuellar, M.D.
What this data tells you about Dr. Puente Cuellar
Dr. Napoleon Puente Cuellar is a pulmonary disease in San Antonio, TX, with 18 years in practice. Based on federal Medicare data, Dr. Puente Cuellar performed 2,611 Medicare services across 1,691 unique beneficiaries.
Between the years covered by Open Payments, Dr. Puente Cuellar received a total of $184,156 from 37 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Puente Cuellar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min | 760 | $163 | $668 |
| Hospital follow-up visit, high complexity | 612 | $91 | $255 |
| Office visit, established patient (30-39 min) | 305 | $89 | $259 |
| Hospital follow-up visit, moderate complexity | 141 | $61 | $177 |
| Initial hospital admission, high complexity | 102 | $133 | $496 |
| Test to examine how well the lungs exchange gases | 97 | $41 | $128 |
| Test to determine lung volumes using sensors | 77 | $40 | $124 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 70 | $27 | $143 |
| New patient office visit (45-59 min) | 42 | $121 | $397 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 37 | $123 | $585 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 36 | $107 | $275 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 35 | $72 | $250 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 32 | $59 | $340 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 31 | $50 | $170 |
| Test to measure expiratory airflow and volume | 31 | $20 | $85 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 27 | $61 | $445 |
| Destruction of growth or narrowing of lung airway using an endoscope | 25 | $185 | $643 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 25 | $64 | $562 |
| 3d radiographic procedure with computerized image postprocessing | 22 | $29 | $153 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 20 | $55 | $475 |
| Insertion of artery tube for blood sampling or infusion through skin | 19 | $34 | $128 |
| Drug injection, under skin or into muscle | 19 | $10 | $60 |
| Insertion of tube connecting vein to vein for hemodialysis | 18 | $89 | $309 |
| Diagnostic exam of lung airway using an endoscope | 15 | $86 | $350 |
| Critical care, each additional 30 minutes | 13 | $82 | $299 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Puente Cuellar is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Puente Cuellar experienced with critical care, first 30-74 min?
Does Dr. Puente Cuellar receive payments from pharmaceutical companies?
How do Dr. Puente Cuellar's costs compare to other pulmonary diseases in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology